The University of Nebraska Medical Center is seeking 24 patients to enroll in a Phase 2a study to evaluate the safety and efficacy of two oral cancer drugs for patients with diffuse large B-cell lymphoma who have relapsed or are resistant to other traditional therapies.

Continued here:
UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

Scroll to Top